Jobs
-
According to NeOnc Technologies, the FDA has approved an expansion of an ongoing Phase 2a trial of the company’s NEO100 intranasal perillyl alcohol to include patients with recurrent grade 3 astrocytoma with isocitrate dehydrogenase 1… Read more . . .
-
Particle characterization specialist Micromeritics Instrument Corporation is set to be acquired by Spectris subsidiary Malvern Panalytical, the companies have announced. According to Spectris, the deal includes a $630 million payment up front and up to… Read more . . .
-
CDMO Kindeva Drug Delivery announced the completion of an FDA inspection at the company’s new laboratory facility in Woodbury, MN, USA and said that the site will continue with routine cGMP audits in the future.… Read more . . .
-
UTMB researchers publish preclinical data on intranasal mAb to prevent Tau accumulation in the brain
The University of Texas Medical Branch announced publication of an article in Science Translational Medicine by UTMB researchers who are developing an intranasal toxic tau conformation–specific monoclonal antibody-2 (TTCM2) to prevent the accumulation of tau protein… Read more . . .
-
FluGen announced that it has published data from a 2022 Phase 1 trial of its M2SR intranasal flu vaccine coadministered with Fluzone high dose intramuscular inactivated influenza vaccine (IIV) in people aged 65 to 85… Read more . . .
-
Merz Therapeutics announced that it has acquired Inbrija inhaled dry powder levodopa from Acorda Therapeutics, which declared bankruptcy earlier this year. Merz had served as a “stalking horse bidder” for the Acorda assets, which also… Read more . . .
-
Vistagen announced that it has been granted patents related to the use of PH80 pherine nasal spray for the treatment of migraine in Australia, Hong Kong, Japan, and Mexico. All four of the new patents… Read more . . .
-
Nocion Therapeutics, whose taplucainium (NTX-1175) DPI is in Phase 2 development for the treatment of chronic cough, has announced the appointments of two former Bellus Health executives, naming Catherine Bonuccelli to the scientific advisory board… Read more . . .
-
Cardiff Scintigraphics, has announced the appointment of OINDP expert John Pritchard as the company’s Chairman of the Board, succeeding David Owen. The news comes soon after Cardiff Scintigraphics, the parent company of inhalation CRO i2c… Read more . . .
-
Disposable dry powder inhaler developer 1nhaler has announced the appointment of former AstraZeneca VP Jane Gaddum as Board Chair and non-executive director and former GSK VP Gordon Muirhead as a non-executive director. Gaddum was AstraZeneca… Read more . . .
Upcoming Events
Sponsored by Intertek
Want information about upcoming OINDP-related events delivered directly to your inbox? click here
October 19-October 20: MVIC Autumn Training 2026, Lund, Sweden
October 21-October 22: MVIC Symposium, Lund, Sweden
November 10-November 11: Rescon Europe 2026, Porto, Portugal
December 9-December 11: DDL 2026, Edinburgh, Scotland